SEP
GSK icon

Signature Equity Partners’s GSK GSK Stock Holding History

Signature Equity Partners’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.7K Sell
166
-2,330
-93% -$123K ﹤0.01% 851
2026
Q1 		$138K Buy
2,496
+2,363
+1,777% +$128K 0.07% 239
2025
Q4 		$6.52K Buy
+133
New +$6.2K ﹤0.01% 927

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Signature Equity Partners's GSK Position: Q2 2026 in Review

Signature Equity Partners reduced its GSK (GSK) stake by 93% in Q2 2026, selling an estimated $123K and leaving 166 shares worth $8.7K. The position accounts for ﹤0.01% of the portfolio, ranked #851.

Signature Equity Partners first reported a position in GSK in Q4 2025 and has held it in 3 quarters since. The position peaked at $138K in Q1 2026. 1,037 funds tracked by Wall St. Rank hold GSK as of Q2 2026.

  • Signature Equity Partners held 166 shares of GSK worth $8.7K as of Q2 2026.
  • Signature Equity Partners sold 2,330 GSK shares in Q2 2026, an estimated $123K.
  • GSK made up ﹤0.01% of Signature Equity Partners's portfolio in Q2 2026, its #851 holding.
  • Signature Equity Partners first reported a position in GSK in Q4 2025 and has held it in 3 quarters since.
  • Signature Equity Partners's GSK position peaked at $138K in Q1 2026.
  • 1,037 funds tracked by Wall St. Rank held GSK as of Q2 2026.

Based on Signature Equity Partners's 13F filing for Q2 2026, filed 30 Jul 2026.